‘Morning people’ have lower breast cancer risk
Body clocks affect sleep, mood and general health - now researchers say they may also indicate cancer risks. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 6, 2018 Category: Consumer Health News Source Type: news

‘Morning people’ are 48 per cent less likely to get breast cancer, major study finds 
The scientists, led by the University of Bristol, also showed women who slept longer than the recommended seven to eight hours a night increased their chances of a diagnosis by 20 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2018 Category: Consumer Health News Source Type: news

Early Birds May Have Lower Breast Cancer Risk
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 6, 2018 Category: Cancer & Oncology Source Type: news

Early Birds May Have Lower Breast Cancer Risk
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - November 6, 2018 Category: Cancer & Oncology Source Type: news

ME & MY OPERATION: Magnetic seeds that makes breast cancer surgery less risky 
Elizabeth Cozens, 78, a retired administrator from Manchester, tried a brand new treatment after being diagnosed with breast cancer. This is her story. (Source: the Mail online | Health)
Source: the Mail online | Health - November 5, 2018 Category: Consumer Health News Source Type: news

Natural matcha green tea extract found to effectively kill breast cancer cells
(Natural News) Green tea might not be grabbing as many health headlines as it did in the past, but that does not mean it isn’t beneficial. In fact, while super foods like turmeric and ginger steal the spotlight, green tea continues to quietly prove its health value in research. In fact, a recent study carried... (Source: NaturalNews.com)
Source: NaturalNews.com - November 5, 2018 Category: Consumer Health News Source Type: news

Amid Deepening Addiction Crisis, FDA Approves Powerful New Opioid
(CNN) — Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approved a new opioid medication five to 10 times more powerful than fentanyl. Dsuvia, made by AcelRx Pharmaceuticals Inc., is a tablet in a single-dose, prefilled applicator to be administered under the tongue by health care providers to patients in settings such as hospitals, surgical centers and emergency rooms, according to the company. FDA Commissioner Dr. Scott Gottlieb was quick to defended the approval in a statement Friday: “The agency is taking new steps to more actively confront this crisis, ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 5, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV opioids Source Type: news

Ghana:Delta Supports Breast Cancer Walk in Tamale
[Ghanaian Times] A record 50,000 health conscious participants took to the principal streets of Tamale for the 2018 version of the acclaimed "BCI Ghana walk for the cure" annual event, designed to increase breast cancer awareness, while celebrating survivorship. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 5, 2018 Category: African Health Source Type: news

Race May Impact Help-Seeking by Women Facing Barriers to Breast Cancer Care Race May Impact Help-Seeking by Women Facing Barriers to Breast Cancer Care
African American women with abnormal mammograms may be less likely than those from other ethnic and racial groups to recognize the barriers to follow-up care that can delay a breast cancer diagnosis or to seek help overcoming them, a U.S. study suggests.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 5, 2018 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Circulating MicroRNAs to Predict Breast Cancer Recurrence Circulating MicroRNAs to Predict Breast Cancer Recurrence
Can plasma microRNA be used to predict breast cancer recurrence years before clinical detection?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 5, 2018 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Women who are 'larks' have a lower risk of developing breast cancer
(National Cancer Research Institute) Women who are 'larks', functioning better at the beginning of the day than the end of the day, have a lower of risk breast cancer, according to new research presented at the 2018 NCRI Cancer Conference on Tuesday. The study looked at several hundred thousand women. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Phobic anxiety is linked to sexuality issues in women who are breast cancer survivors
(University of C ó rdoba) A University of Cordoba research project reveals that mental well-being is a determining factor in sexual dysfunction in women affected by this kind of cancer. Psychological variables are determining factors in sexuality development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

Breast cancer cells become invasive by changing their identity
(Karolinska Institutet) Researchers from Karolinska Institutet in Sweden have identified a protein that determines the identity and invasive properties of breast cancer cells. The finding could lead to the development of new therapeutic and diagnostic strategies to target breast cancer invasion and metastasis. The study is published in the scientific journal Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 5, 2018 Category: Cancer & Oncology Source Type: news

She Chose To 'Go Flat' And Wants Other Breast Cancer Survivors To Know They Can Too
After her double mastectomy, writer Catherine Guthrie came to embrace her new body, without breast reconstruction. But she's learned, women have to push the medical system to support this choice.(Image credit: Courtesy of Catherine Guthrie) (Source: NPR Health and Science)
Source: NPR Health and Science - November 2, 2018 Category: Consumer Health News Authors: Rachel D. Cohen Source Type: news

Uganda:300 Breast Cancer Patients, Survivors Get Donations
[Monitor] Kampala -About 345 breast cancer patients and survivors at Uganda Cancer Institute in Mulago have received physical and psycho-social support from Jubilee Insurance Company. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 2, 2018 Category: African Health Source Type: news

Do NSAIDs Prevent Breast Cancer Recurrence? Do NSAIDs Prevent Breast Cancer Recurrence?
While it has been suggested that NSAIDs may reduce cancer recurrence, a new study finds this not to be the case.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 2, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

A prognostic model may predict survival in African-American women with breast cancer
(American Association for Cancer Research) A prognostic model developed using a machine learning approach could identify African-American breast cancer patients with increased risk of death. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: news

Coverage of hormonal breast cancer therapies increased in states that expanded Medicaid
(American Association for Cancer Research) An evaluation of breast cancer patients enrolled in Medicaid showed that states that expanded Medicaid during 2011 to 2017 had a 27 percent increase in prescriptions for hormonal therapy medications compared to states that did not expand Medicaid during the same period. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: news

How Understanding Breast Density Has Transformed the Future of Radiology
The problem of density and what it has meant for radiologists. (Source: Diagnostic Imaging)
Source: Diagnostic Imaging - November 1, 2018 Category: Radiology Authors: Regina Hooley, M.D Tags: Breast Cancer Breast Imaging Dense Breasts Source Type: news

Is a Shorter Trastuzumab Duration a Cost-Effective Option in HER2+ Breast Cancer?
Researchers compared the cost effectiveness of two durations of trastuzumab in HER2+ breast cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - November 1, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

23andMe Can Now Tell You How You May Respond to Some Drugs. But Experts Are Wary
Consumer genetics company 23andMe on Wednesday became the first to secure Food and Drug Administration (FDA) approval for a report that provides information about how a person’s genetics may impact the efficacy of certain drugs. The approval, which comes with certain caveats and safety controls, expands the company’s ability to offer medical insights to customers — but some experts say that information should be approached with caution. This is the latest consumer advance in pharmacogenetics, or the study of how a person’s genes may alter the effects of certain drugs, including blood thinners and an...
Source: TIME: Health - November 1, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Genetics healthytime Source Type: news

Breast cancer mutation increases interval cancer risk
Women who carry a certain rare breast cancer mutation are more likely to develop...Read more on AuntMinnie.comRelated Reading: Dense breast tissue translates into higher cancer odds Age, not density, predicts interval breast cancer result Automated breast density assessment informs cancer risk Visual aid pinpoints women at high risk of breast cancer Set your breast clinic apart with risk-based resources (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 1, 2018 Category: Radiology Source Type: news

Race may impact help-seeking by women facing barriers to breast cancer care
(Reuters Health) - African American women with abnormal mammograms may be less likely than those from other ethnic and racial groups to recognize the barriers to follow-up care that can delay a breast cancer diagnosis or to seek help overcoming them, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Kenya:Cancer Warrior - a Bundle of Joy in the Middle of Gloom
[Nation] Lucky Ndanu was only 23 when she was diagnosed with breast cancer. The 33-year-old cancer warrior, mother, data analyst and project manager talks to Nation.co.ke about her journey. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 1, 2018 Category: African Health Source Type: news

Africa:Early Detection Vital to Treating Breast Cancer
[CAJ News] Johannesburg -SOUTH African women have been encouraged to have their breast health monitored regularly in order to detect breast cancer at an early stage. At that stage, treatment has the best chance of success. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 1, 2018 Category: African Health Source Type: news

Nigeria:Lagoon Hospitals Engage Residents On Awareness Walk to Prevent Breast Cancer
[Guardian] In its bid to reduce the scourge of cancer in Nigeria, Lagoon hospitals, at the weekend, engaged residents of Victoria Island, Lagos on a breast cancer awareness walk on early detection, treatment, and the need for a reliable, permanent cure. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 1, 2018 Category: African Health Source Type: news

Women carrying rare breast cancer variants more likely to develop interval breast cancers
(American Association for Cancer Research) While the presence of common breast cancer mutations was indicative of increased breast cancer risk, the presence of certain rare mutations was indicative of increased risk from interval breast cancers and death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2018 Category: International Medicine & Public Health Source Type: news

Clinical pathway programme high-value care in breast cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2018 Category: Drugs & Pharmacology Source Type: news

Genetic Risk Score IDs Breast CA Risk in Female Child CA Survivors
Survivors in highest quintile of polygenic risk score have increased relative rate of breast cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 31, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news

First PI3K Inhibitor to Improve Outcomes in HR+/HER2 − Breast Cancer
The SOLAR-1 trial tested whether the PI3K inhibitor alpelisib improved outcomes in HR+, HER2 − breast cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - October 31, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Researchers identify patients facing greatest risk of cancer's return
St. Jude researchers believe gene variations could help identify pediatric cancer survivors who are especially likely to face a breast cancer diagnosis later in life. The findings of a new St. Jude Children’s Research Hospital study determined that childhood cancer survivors with a specific combination of genetic variations are at a much higher risk of breast cancer compared to other survivors of pediatric cancers. Researchers found the combined effect of th e 170 common gene variations is comparable… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 31, 2018 Category: American Health Authors: Caitlin Mullen Source Type: news

Male Breast Cancer: Current Clinical Practice'Justified'Male Breast Cancer: Current Clinical Practice'Justified '
Despite differences in demographic and disease-related characteristics, male breast cancer patients are treated similarly to female patients, with similar outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Genetic Risk Score IDs Breast CA Risk in Female Child CA Survivors
WEDNESDAY, Oct. 31, 2018 -- A polygenic risk score (PRS) can identify subsequent breast cancer risk among childhood survivors of cancer, according to a study published online Oct. 26 in Clinical Cancer Research. Zhaoming Wang, Ph.D., from St. Jude... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2018 Category: Pharmaceuticals Source Type: news

Sex hormone blocker increases likelihood of pregnancy in breast cancer patients
The sex hormone blocker, goserelin, protects the ovaries from breast cancer chemotherapy, improving the likelihood of future pregnancy, according to research published in theJournal of the National Cancer Institute. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 31, 2018 Category: Endocrinology Source Type: news

Boosting confidence after breast cancer in Salisbury
This case study illustrates how cancer survivors in Salisbury feel more confident and less fatigued after enhanced support to live better after cancer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 31, 2018 Category: Consumer Health News Source Type: news

Dermoscopy of Skin Metastases From Breast Cancer Dermoscopy of Skin Metastases From Breast Cancer
This report highlights the utility of dermoscopy for accurate diagnosis of cutaneous metastatic breast cancer, describing dermoscopic patterns of the disease.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Social media could help raise breast screening take-up
First-time attendances rose by 13% in Stoke-on-Trent after project through Facebook groups Related items fromOnMedica NICE rejects breast cancer drug for NHS funding Women who lost weight had lower breast cancer risk NICE rejects adjuvant use of breast cancer drug Cancer diagnosis via screening offers best outcomes (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 31, 2018 Category: UK Health Source Type: news

New Method Estimates Risk for Recurrence in Breast Cancer
Higher recurrence risk linked to older age, more advanced stage, HR - negative tumors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 30, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Another Analysis of Trastuzumab for Only 9 Weeks: Not an Option Another Analysis of Trastuzumab for Only 9 Weeks: Not an Option
A 9-week course of trastuzumab for low- and intermediate-risk early breast cancer looks possible but is not recommended as a standard of care according to experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 30, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

#DYK: Mammograms are still the best tool for breast cancer screening. Check out @US_FDA ’ s information on the importance of choosing a certified mammography facility: https://go.usa.gov/xPPpT   #MedicalDevice #BreastCancerAwarenessMonthpic.twitter.com/YaGqeGgrTH
#DYK: Mammograms are still the best tool for breast cancer screening. Check out @US_FDA’s information on the importance of choosing a certified mammography facility: https://go.usa.gov/xPPpT  #MedicalDevice #BreastCancerAwarenessMonth pic.twitter.com/YaGqeGgrTH (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 30, 2018 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

New Method Estimates Risk for Recurrence in Breast Cancer
TUESDAY, Oct. 30, 2018 -- The risk for breast cancer recurrence can be extracted using disease-specific survival data, according to a study published online Oct. 18 in Cancer Epidemiology, Biomarkers& Prevention. Angela B. Mariotto, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2018 Category: Pharmaceuticals Source Type: news

UC researchers developing test for early breast lesions
(University of Cincinnati Academic Health Center) Researchers at the University of Cincinnati (UC) are investigating a molecular diagnostic test to determine whether, after biopsy, someone is at high or low risk for actually developing malignant breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2018 Category: Cancer & Oncology Source Type: news

City of Hope opens CAR T trial for HER2 breast cancer patients with brain metastases
(City of Hope) Women with HER2-positive breast cancer that has spread to the brain need more treatment options, and City of Hope and Mustang Bio Inc. are meeting that challenge. A new City of Hope chimeric antigen receptor (CAR) T cell trial -- the first to focus on HER2-postive breast cancer patients with brain metastases -- is now enrolling potential participants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 30, 2018 Category: International Medicine & Public Health Source Type: news

'I never knew men could get breast cancer'
Moses Musonga, a 67-year-old Kenyan, got a shock when he was diagnosed with the disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 30, 2018 Category: Consumer Health News Source Type: news

Mayo Clinic Minute: Can you prevent breast cancer?
Breast cancer is the most common cancer in women, according to the Centers for Disease Control and Prevention. Dr. Karthik Ghosh says, no matter what your personal risk is, there are ways that may help lower your chances of getting the disease. https://youtu.be/H_RpoHB-jYM Watch: The Mayo Clinic Minute Journalists: Broadcast-quality video pkg (0:59) is in [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 30, 2018 Category: Databases & Libraries Source Type: news

FDA committed to studying breast implant safety
By Dr. Binita Ashar, director of the division of surgical devices in the FDA’s Center for Devices and Radiological Health Choosing to obtain a breast implant, whether for augmentation or reconstruction, is a deeply personal choice, from the initial decision to undergo breast implant surgery to the size, material and surface texture. These types of decisions should be discussed between a patient and their provider in a transparent and balanced way with clear information about the benefits and risks of the breast implants and the procedure. As a public health agency, we play an important role in ensuring that patients ...
Source: Mass Device - October 29, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog FDA Voice Source Type: news

DBT doesn't hurt screening throughput
Implementing digital breast tomosynthesis (DBT) at a breast center doesn't...Read more on AuntMinnie.comRelated Reading: DBT spots 34% more breast cancers than mammography DBT plus ABVS offers a breast cancer staging alternative Synthesized 2D similar to FFDM for finding microcalcs Breast MRI works for evaluating equivocal DBT findings Could DBT change the equation of screening younger women? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 29, 2018 Category: Radiology Source Type: news

Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'
(American Society for Radiation Oncology) A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news

Long-term side effects similarly low for weekly, conventional breast radiation, trial finds
(American Society for Radiation Oncology) In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer, larger individual doses experienced similarly low rates of late-onset side effects as those undergoing conventional radiation therapy. Findings from the multi-institutional U.K. FAST clinical trial were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news

Hormone-blocking injections reduce early menopause from breast cancer treatment
(SWOG) Final results of SWOG Cancer Research Network's groundbreaking international Prevention of Early Menopause Study (POEMS) clinical trial are in, and they show continued evidence that women who get injections of the hormone drug goserelin along with standard breast cancer chemotherapy are more likely to become pregnant - without developing negative side effects or shortening their lives. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 29, 2018 Category: International Medicine & Public Health Source Type: news